Waldemar Różański

Author

Waldemar Różański

Also Known As

Marek Lipiński, W Rózański, W Różański, W. Rozanski, W. Rózanski, W. Różanski, W. Różański, W. Róžanski, WALDEMAR RÓŻAŃSKI, Waldemar Rozanski

101

Publications

946

Citations

H-Index

Concepts

All Affiliations

Medical University of Lodz University of Łódź Medical University of Warsaw Medical University of Silesia Pomeranian Medical University

About

Waldemar Różański is an author at Medical University of Lodz specializing in medicine, urology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	305
2	Engineering	2	2	53
3	Public Health	1	1	34
4	Environmental Engineering	1	1	23
5	General Surgery	1	1	14

Waldemar Różański

Publications

827

Citations

H-Index

Page 1

	Year	Citations
An inherited NBN mutation is associated with poor prognosis prostate cancer Cezary Cybulski, Dominika Wokołorczyk, Wojciech Kluźniak, British Journal of Cancer	2012	98
Relationship Between Urinary Tract Infection and Self-Retaining Double-J Catheter Colonization Ewa Korczak-Kozakiewicz, Andrzej Denys, Marek Sosnowski, Journal of Endourology Catheter SurfaceUrological ResearchUrologyVoiding DysfunctionMedicine	2009	78
Prediction of bladder cancer based on urinary content of MGEA5 and OGT mRNA level. Waldemar Różański, Anna Krześlak, Ewa Forma, PubMed	2012	58
BPH Thulium laser enucleation of the prostate (TmLEP) vs. transurethral resection of the prostate (TURP): evaluation of early results Piotr Świniarski, S Stepień, W. Dudzic, Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication	2012	49
Metallothionein 2A genetic polymorphisms and risk of ductal breast cancer Anna Krześlak, Ewa Forma, Paweł Jóźwiak, Clinical and Experimental Medicine	2012	46
Validation of EORTC, CUETO, and EAU risk stratification in prediction of recurrence, progression, and death of patients with initially non–muscle‐invasive bladder cancer (NMIBC): A cohort analysis Mateusz Jobczyk, Konrad Stawiski, Wojciech Fendler, Cancer Medicine	2020	42
Effect of metallothionein 2A gene polymorphism on allele-specific gene expression and metal content in prostate cancer Anna Krześlak, Ewa Forma, Grażyna Chwatko, Toxicology and Applied Pharmacology UrologyGene PolymorphismHuman PolymorphismAllele-specific Gene ExpressionProstatic Disease	2013	38
PALB2 mutations and prostate cancer risk and survival Dominika Wokołorczyk, Wojciech Kluźniak, Klaudia Stempa, British Journal of Cancer UrologyMedicineProstatic DiseasePalb2 MutationsCancer Genetics	2021	38
The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland Wojciech Kluźniak, Dominika Wokołorczyk, Aniruddh Kashyap, The Prostate	2013	34
Metallothionein 2A genetic polymorphisms and risk of prostate cancer in a Polish population Ewa Forma, Anna Krześlak, Jacek Wilkosz, Cancer Genetics UrologyCancer RiskCancer EpidemiologyMetallothionein 2AGenetic Epidemiology	2012	34

Page 1